Enphase Named Top Residential PV Monitoring Vendor in North America
Oct 04, 2017 13:01 pm UTC| Business
PETALUMA, Calif., Oct. 04, 2017 -- Enphase Energy, Inc. (NASDAQ:ENPH), a global energy technology company and the world’s leading supplier of solar microinverters, has been named the #1 residential PV monitoring vendor...
Costco Auto Program Most Sought-After Promotion Returns
Oct 04, 2017 13:01 pm UTC| Business
SAN DIEGO, Oct. 04, 2017 -- Costco Auto Program today announced the Holiday Sales Event, its most prominent promotion in conjunction with General Motors, on a wide selection of 2017 and 2018 Chevrolet, Buick, GMC and...
Celsion to Host Research and Development Update October 12, 2017
Oct 04, 2017 13:01 pm UTC| Business
LAWRENCEVILLE, N.J., Oct. 04, 2017 -- Celsion Corporation (NASDAQ:CLSN), an oncology development company, today announced that it will host a Research and Development (RD) Day for investors and analysts on Thursday,...
Check Point Software to Announce 2017 Third Quarter Financial Results on October 31, 2017
Oct 04, 2017 13:01 pm UTC| Business
SAN CARLOS, Calif., Oct. 04, 2017 -- Check Point® Software Technologies Ltd. (NASDAQ:CHKP), the largest pure-play network cyber security vendor globally, today announced that it will release its third quarter financial...
Top Insurer Pioneers MTBC’s Newest SaaS Solution
Oct 04, 2017 13:01 pm UTC| Business
SOMERSET, N.J. , Oct. 04, 2017 -- MTBC (NASDAQ: MTBC) (NASDAQ: MTBCP), a leading provider of proprietary, cloud-based technology solutions today announced that one of the 10 largest insurance carriers in the United...
Zoomdata Achieves AWS Big Data Competency Status
Oct 04, 2017 13:01 pm UTC| Business
SAN MATEO, Calif., Oct. 04, 2017 -- Zoomdata, developers of the world's fastest visual analytics platform for Big Data, has earned Amazon Web Services (AWS) Big Data Competency status. The designation recognizes that...
Inspyr Therapeutics Announces Research Collaboration with NYU Winthrop Hospital
Oct 04, 2017 13:01 pm UTC| Business
WESTLAKE VILLAGE, Calif., Oct. 04, 2017 -- Inspyr Therapeutics (OTCQB:NSPX), a clinical-stage biotechnology company, announced the initiation of a new investigator-sponsored preclinical study of its proprietary...